This question is particularly important in light of a potential role of human SLC26A9 to compensate for the loss of CFTR mediated Cl– transport in patients suffering from cystic fibrosis (Balázs and Mall, 2018; Mall and Galietta, 2015). This evidence concerns the gene CFTR and cystic fibrosis.